NCT02466568 2019-09-09
Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Withdrawn
H. Lee Moffitt Cancer Center and Research Institute
Universitätsmedizin Mannheim
Imunon
University of Arkansas